Pathogenesis and Personalized Management of Asthma
A special issue of Journal of Personalized Medicine (ISSN 2075-4426). This special issue belongs to the section "Mechanisms of Diseases".
Deadline for manuscript submissions: 20 July 2026 | Viewed by 329
Special Issue Editors
Interests: molecular diagnostics of allergic disease, asthma, and lung cancer
2. School of Clinical and Experimental Sciences, Faculty of Medicine, University of Southampton, Southampton SO17 1BJ, UK
3. The David Hide Asthma and Allergy Research Centre, Newport PO30 5TG, Isle of Wight, UK
Interests: allergy; immunology; immunity; asthma
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Asthma is a chronic, heterogeneous airway disease affecting millions worldwide, with significant morbidity and healthcare burden. Despite decades of research, asthma remains difficult to diagnose, classify, and manage effectively, highlighting the need for deeper mechanistic insights and personalised approaches. This Special Issue aims to advance the understanding of asthma pathogenesis and foster the development of precision medicine strategies, integrating basic, translational, and clinical research.
We welcome studies on novel molecular biomarkers, multi-omics profiling, innovative therapeutic targets, and data-driven personalised care models for asthma. We invite original research, systematic reviews, meta-analyses, and thought-provoking perspectives that address the mechanisms, diagnosis, prognosis, and personalised management of asthma.
Dr. Mohammed Aref Kyyaly
Prof. Dr. S. Hasan Arshad
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Personalized Medicine is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- asthma
- pathogenesis
- biomarkers
- personalized medicine
- precision therapy
- severe asthma
- immunopathology
- molecular diagnostics
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
